MedPath

Prediction of Extubation Readiness in Extreme Preterm Infants by the Automated Analysis of CardioRespiratory Behavior

Completed
Conditions
Prediction of Extubation Readiness
Interventions
Other: Cardiorespiratory signal acquisition
Registration Number
NCT01909947
Lead Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Brief Summary

The investigators hypothesize that machine learning methods using a combination of novel, quantitative measures of cardio-respiratory variability can accurately predict the optimal time to extubate extreme preterm infants. In this multicenter prospective study, cardiorespiratory signals will be recorded from 250 extreme preterm infants who are eligible for extubation. Automated signal analysis algorithms will compute a variety of metrics for each infant describing the cardiorespiratory state. Machine learning methods will then be used to find the optimal combination of these statistical measures and clinical features that provide the best overall predictor of extubation readiness. Finally, investigators will develop an Automated system for Prediction of EXtubation (APEX) that will integrate the software for data acquisition, signal analysis, and outcome prediction into a single application suitable for use by medical personnel in the Neonatal Intensive Care Unit (NICU). The performance of APEX will later be clinically validated in 50 additional infants prospectively.

Detailed Description

At birth, extreme preterm infants (≤28 weeks) have inconsistent respiratory drive, airway instability, surfactant deficiency and immature lungs that frequently result in respiratory failure. Management of these infants is difficult and most will require endotracheal intubation and mechanical ventilation (ETT-MV) within the first days of life to survive. ETT-MV is an invasive therapy that is associated with adverse clinical outcomes including ventilator-associated pneumonia, impaired neurodevelopment, and increased mortality. Consequently, clinicians try to remove ETT-MV as quickly as possible. However, 25 to 35% of these extubation attempts will fail and infants will require reintubation, an intervention that is also associated with increased morbidity and mortality. Therefore physicians must determine the optimal time for extubation which minimizes the duration of ETT-MV and maximizes the chances of success. A variety of objective measures have been proposed to assist with this decision but none has proven to be useful clinically. Investigators from this group have recently explored the predictive power of indices of autonomic nervous system function based on measurements of heart rate (HRV) and respiratory variability (RV). The use of sophisticated, automated algorithms to analyze those cardiorespiratory signals have shown some promising preliminary results in predicting which infants can be extubated successfully.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
266
Inclusion Criteria
  • All infants admitted to the NICU with a birth weight ≤ 1250 grams AND
  • Need for endotracheal tube mechanical ventilation
Exclusion Criteria
  • Infants with major congenital anomalies
  • Infants with congenital heart disease and cardiac arrhythmias
  • Infants receiving vasopressor or sedative drugs at the time of extubation
  • Infants extubated directly from high frequency ventilation
  • Infants extubated to room air, oxyhood or low-flow nasal cannula

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Intubated extreme preterm infantsCardiorespiratory signal acquisitionInfants with a birth weight ≤ 1250 grams and requiring endotracheal tube and mechanical ventilation
Primary Outcome Measures
NameTimeMethod
Extubation FailureWithin 72 hours of extubation

Infants will be considered to have failed extubation if they meet one or more of the following criteria within 72 hours of extubation:

1. Fraction of inspired oxygen (FiO2) \> 0.5 in order to maintain oxygen saturation (SpO2) \> 88% or PaO2 \> 45 mmHg (for 2 consecutive hours)

2. PaCO2 \> 55-60 mmHg with a pH \< 7.25 in two consecutive blood gases done 1-2 hours apart

3. 1 episode of apnea requiring positive pressure ventilation with bag and mask

4. Multiple episodes of apnea (≥ 6 episodes / 6 hours).

Secondary Outcome Measures
NameTimeMethod
The need for reintubationAnytime from the first planned extubation until discharge from the neonatal intensive care unit

Infants will be prospectively followed from birth until discharge from the NICU. Therefore, infants who require reintubation at any time point from the first planned extubation until discharge from the neonatal intensive care unit will be documented

The need for reintubation within 72h of the first planned extubationWithin 72 hours of extubation

The decision to re-intubate will be made by the responsible physician, who may not always follow the guidelines stated in the primary objective. Therefore, reintubation will be assessed as a secondary outcome.

Trial Locations

Locations (5)

Royal Victoria Hospital

🇨🇦

Montreal, Quebec, Canada

Wayne State University

🇺🇸

Detroit, Michigan, United States

Montreal Children's Hospital

🇨🇦

Montreal, Quebec, Canada

Jewish General Hospital

🇨🇦

Montreal, Quebec, Canada

Women and Infants Hospital of Rhode Island

🇺🇸

Providence, Rhode Island, United States

© Copyright 2025. All Rights Reserved by MedPath